GENNA SADLER: Open Payments
NPI 1164867958 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 25 payments from 12 companies in 2025. Trend: 2023 $134 · 2024 $1,520 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $321 |
| Ferring Pharmaceuticals Inc. | 1 | $164 |
| COLOPLAST CORP | 1 | $79 |
| 180 Medical, Inc. | 1 | $60 |
| TOLMAR, INC. | 2 | $56 |
| Medtronic, Inc. | 2 | $47 |
| Endo USA, Inc. | 2 | $41 |
| UROGEN PHARMA, INC. | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: GEMTESA, ADSTILADRIN, ORGOVYX, Luja Coude, ELIGARD, INTERSTIM, XIAFLEX, ZUSDURI.
Industry payments across KY — which companies pay providers there.
